Jim Grady
Consultant
Jim Grady is a Consultant at Back Bay Life Science Advisors, where he advises a diverse portfolio of clients, from emerging biotech and medtech innovators to large-cap pharmaceutical leaders. Building on a career defined by technical and financial rigor, Jim has extended his expertise at the firm across indication prioritization, commercial and portfolio strategy, due diligence, and enterprise and asset valuation.
His recent workstreams at Back Bay focus on high-growth areas, including various advanced modalities, neuromuscular, I&I, oncology, and the rapidly evolving metabolic and obesity landscape. Jim partners with clients to develop NPV and revenue models, assess market access for novel drugs and biologics, and guide portfolio strategy for clients.
Prior to joining Back Bay in 2024, Jim held business development and commercial strategy roles at Rallybio and served as an Associate Consultant at Boulder Biotech Launch Specialists. He also brings a strong understanding of financial modeling, credit, and corporate finance from his earlier experience at CoBank, a large corporate bank.
Jim holds an MBA in Corporate Finance from the University of Notre Dame and BSc degrees in Chemical & Biological Engineering and Business Administration (Finance) from the University of Colorado Boulder. He leverages this multidisciplinary background to bridge the gap between technical innovation and commercial success.
Recent Articles: